Celularity Inc. Class A Common Stock
Symbol: CELU (NASDAQ)
2.05
▼ (-1.21%) -0.025
Company Description:
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
Key Stats
- Today's Open: $2.11
- Today's High: $2.172
- Today's Low: $2.045
- Today's Volume: 111.53K
- Yesterday Close: $2.07
- Yesterday High: $2.2071
- Yesterday Low: $2.03
- Yesterday Volume: 73.88K
- Last Min Volume: 6
- Last Min High: $2.045
- Last Min Low: $2.045
- Last Min VWAP: $2.045
Company Profile
- Name: Celularity Inc. Class A Common Stock
- Website: https://www.celularity.com
- Listed Date: 2021-07-19
- Location: FLORHAM PARK, NJ
- Market Status: Active
- CIK Number: 0001752828
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $55.25M
- Round Lot: 100
- Outstanding Shares: 26.69M
- Asset Type: CS
RECENT FILINGS FOR CELU
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 8-K | View |
| 2025-08-29 | 10-Q | View |
| 2025-08-29 | 10-Q | View |
| 2025-08-27 | SCHEDULE 13G | View |
| 2025-08-18 | 8-K | View |
| 2025-08-12 | 8-K | View |
| 2025-08-05 | D | View |
| 2025-08-05 | D | View |
| 2025-08-05 | D | View |
| 2025-08-01 | 8-K | View |
| 2025-07-30 | 8-K | View |
| 2025-07-29 | 8-K/A | View |
| 2025-07-28 | SCHEDULE 13D/A | View |
| 2025-07-28 | 4 | View |
| 2025-07-28 | 4 | View |
| 2025-07-22 | 8-K | View |
| 2025-07-16 | 3 | View |
| 2025-07-10 | 3 | View |
| 2025-06-10 | 8-K | View |
| 2025-06-06 | 8-K | View |
Latest News on CELU